Literature DB >> 19917890

Prognostic implications of myocardial perfusion single-photon emission computed tomography in the elderly.

Rory Hachamovitch1, Xingping Kang, Aman M Amanullah, Aiden Abidov, Sean W Hayes, John D Friedman, Ishac Cohen, Louise E J Thomson, Guido Germano, Daniel S Berman.   

Abstract

BACKGROUND: The goal of this study was to assess the clinical value of stress myocardial perfusion scintigraphy (MPS) in elderly patients (> or =75 years of age). METHODS AND
RESULTS: We followed up 5200 elderly patients (41% exercise) after dual-isotope MPS over 2.8+/-1.7 years (362 cardiac deaths [CDs], 7.0%, 2.6%/y) and a subset with extended follow-up (684 patients for 6.2+/-2.9 years; 320 all-cause deaths). Survival modeling of CD revealed that both MPS-measured ischemia and fixed defect added incrementally to pre-MPS data in both adenosine and exercise stress patients. Modeling a subset with gated MPS (n=2472) revealed that ejection fraction and perfusion data added incrementally to each other, further enhancing risk stratification. Unadjusted, annualized post-normal MPS CD rate was 1.3% but <1% in patients with normal rest ECG, exercise stress, or age of 75 to 84 years and was 2.3% to 3.7% in patients > or =85 years of age or undergoing pharmacological stress. However, compared with age-matched US population CD rates (75 to 84 years of age, 1.5%; > or =85 years, 4.8%), normal MPS CD rates were approximately one-third lower than the baseline risk of US individuals (both P<0.05). Modeling of all-cause death in 684 patients with extended follow-up revealed that after risk adjustment, an interaction between early treatment and ischemia was present; increasing ischemia was associated with increasing survival with early revascularization, whereas in the setting of little or no ischemia, medical therapy had improved outcomes.
CONCLUSIONS: Stress MPS effectively stratifies CD risk in elderly patients and may identify optimal post-MPS therapy. CD rates after normal MPS are low in all subsets in relative terms compared with the age-matched US population.

Entities:  

Mesh:

Year:  2009        PMID: 19917890     DOI: 10.1161/CIRCULATIONAHA.108.817387

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  48 in total

1.  Prognostic value of automated vs visual analysis for adenosine stress myocardial perfusion SPECT in patients without prior coronary artery disease: a case-control study.

Authors:  Yuan Xu; Ryo Nakazato; Sean Hayes; Rory Hachamovitch; Victor Y Cheng; Heidi Gransar; Romalisa Miranda-Peats; Mark Hyun; Leslee J Shaw; John Friedman; Guido Germano; Daniel S Berman; Piotr J Slomka
Journal:  J Nucl Cardiol       Date:  2011-09-20       Impact factor: 5.952

2.  The clinical value of single photon emission computed tomography myocardial perfusion imaging in cardiac risk stratification of very elderly patients (≥80 years) with suspected coronary artery disease.

Authors:  Sanjeev U Nair; Alan W Ahlberg; Shishir Mathur; Deborah M Katten; Donna M Polk; Gary V Heller
Journal:  J Nucl Cardiol       Date:  2011-11-10       Impact factor: 5.952

Review 3.  Prognosis in the era of comparative effectiveness research: where is nuclear cardiology now and where should it be?

Authors:  Leslee J Shaw; Fadi G Hage; Daniel S Berman; Rory Hachamovitch; Ami Iskandrian
Journal:  J Nucl Cardiol       Date:  2012-10       Impact factor: 5.952

Review 4.  Quantitative analysis of perfusion studies: strengths and pitfalls.

Authors:  Piotr Slomka; Yuan Xu; Daniel Berman; Guido Germano
Journal:  J Nucl Cardiol       Date:  2012-04       Impact factor: 5.952

5.  Risk stratification for large artery or chronic coronary artery disease-related ischemic stroke in octogenarians undergoing exercise stress myocardial perfusion imaging: A cohort study.

Authors:  Athanasios Katsikis; Athanasios Theodorakos; Alexandros Drosatos; Konstantinos Konstantinou; Spyridon Papaioannou; Maria Koutelou
Journal:  J Nucl Cardiol       Date:  2015-12-16       Impact factor: 5.952

6.  Choosing exercise or pharmacologic stress imaging, or exercise ECG testing alone: How to decide.

Authors:  Jorge A Gonzalez; George A Beller
Journal:  J Nucl Cardiol       Date:  2016-02-03       Impact factor: 5.952

7.  Myocardial perfusion scans: projected population cancer risks from current levels of use in the United States.

Authors:  Amy Berrington de Gonzalez; Kwang-Pyo Kim; Rebecca Smith-Bindman; Dorothea McAreavey
Journal:  Circulation       Date:  2010-11-22       Impact factor: 29.690

8.  Myocardial perfusion imaging in very elderly patients with suspected coronary artery disease: never too late!

Authors:  Pasquale Perrone-Filardi; Alberto Cuocolo; Santo Dellegrottaglie
Journal:  J Nucl Cardiol       Date:  2012-04       Impact factor: 5.952

9.  Prognosis in patients with suspected or known ischemic heart disease and normal myocardial perfusion: long-term outcome and temporal risk variations.

Authors:  Jane A Simonsen; Oke Gerke; Charlotte K Rask; Mohammad Tamadoni; Anders Thomassen; Søren Hess; Allan Johansen; Hans Mickley; Lisette O Jensen; Jesper Hallas; Werner Vach; Poul F Høilund-Carlsen
Journal:  J Nucl Cardiol       Date:  2013-03-01       Impact factor: 5.952

Review 10.  Medical Therapy With Versus Without Revascularization in Stable Patients With Moderate and Severe Ischemia: The Case for Community Equipoise.

Authors:  Gregg W Stone; Judith S Hochman; David O Williams; William E Boden; T Bruce Ferguson; Robert A Harrington; David J Maron
Journal:  J Am Coll Cardiol       Date:  2015-11-23       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.